Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Public ClinicalTrials.gov record NCT01361607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind, Randomized, Placebo-controlled, Parallel Group Study of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 9-week study aimed to determine the efficacy, safety, and tolerability of nabiximols (Sativex®) as an adjunctive treatment, compared with placebo in relieving uncontrolled persistent chronic pain in participants with advanced cancer. Eligible participants were not required to stop any of their current treatments or medications.
Study identification
- NCT ID
- NCT01361607
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 399 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2011 (Actual)
- Primary completion
- Nov 24, 2014 (Actual)
- Completion
- Nov 24, 2014 (Actual)
- Last update posted
- Apr 12, 2023
2011 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | California | 91204 | — |
| Not listed | Santa Rosa | California | 95403 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Holiday | Florida | 34691 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Stuart | Florida | 34994 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Newnan | Georgia | 30265 | — |
| Not listed | Stockbridge | Georgia | 30281 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Mount Vernon | Illinois | 62864 | — |
| Not listed | Ashland | Kentucky | 41101 | — |
| Not listed | Bossier City | Louisiana | 71111 | — |
| Not listed | Shreveport | Louisiana | 71105 | — |
| Not listed | Missoula | Montana | 59802 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | New York | New York | 10010-4086 | — |
| Not listed | Cleveland | Ohio | 44119 | — |
| Not listed | Lacey | Washington | 98503-1010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01361607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01361607 live on ClinicalTrials.gov.